SLC22A1 and chronic myelogenous leukemia, BCR-ABL1 positive: Among these, SLC22A1 rs628031 (tagged to rs594709 in Asian) was reported to affect imatinib uptake in chronic myeloid leukemia (CML) cell line [14].